Prostate Carcinoma — Trials

Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,176 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 230
Ph III recruiting: 20
Growth YoY: −2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (184)

clinicaltrialsPublishedShowing 201–250 of 1,176 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06517719	Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer	recruiting	—	500	Novartis PharmaceuticalsINDUSTRY	1	Jul 13, 2026	clinicaltrials
NCT04037254	Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring	completed	Phase 1 / Phase 2	22	NRG OncologyOTHER	2	Jul 10, 2026